News

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss ...

Eisai/Biogen, Eli Lilly highlight long-term data backing Alzheimer’s drugs

Eisai (OTCPK:ESALF) and Eli Lilly (NYSE:LLY) on Wednesday announced data from long-term extension studies for their ...